Causes and treatment of bone pain of malignant origin
- PMID: 8882377
- DOI: 10.2165/00003495-199651030-00004
Causes and treatment of bone pain of malignant origin
Abstract
Pain relief has been one of the oldest and most important duties of the physician. There has been little change with regard to this obligation of all caregivers. One-third of patients with advanced cancer will develop clinically relevant skeletal metastases and chronic pain during the course of their disease. All physicians involved in the treatment of cancer patients should know the basic principles of pain treatment. These are described in the following article with special regard to bone pain of malignant origin. Correct assessment of pain intensity and frequency, as well as of the probable causes of pain, and the administration of adequate analgesic treatment should achieve satisfactory results in the vast majority of patients. Every physician should obtain detailed knowledge of the indications and adequate administration of pain-killing therapy as well as possible adverse effects and their successful treatment. It is important in particular to concentrate on a few nonsteroidal anti-inflammatory drugs (NSAIDs) as well as opiates. Knowledge of adequate doses, maximal recommended daily doses, pharmacological properties, important adverse effects and interactions is essential for success in the daily routine. Only by selecting 2 or 3 drugs from each step in the analgesic ladder (WHO) will the nonspecialised physician obtain sufficient experience for optimal analgesia. Physicians should also not hesitate to contact other specialists (medical oncologists, radiotherapists, neurosurgeons, anaesthesiologists and others) in order to maximise benefit for an individual patient.
Comment in
-
Relief of pain from osseous metastatic lesions.Drugs. 1996 Sep;52(3):475. doi: 10.2165/00003495-199652030-00014. Drugs. 1996. PMID: 8875134 No abstract available.
Similar articles
-
Daily subcutaneous parecoxib injection for cancer pain: an open label pilot study.J Palliat Med. 2015 Apr;18(4):366-72. doi: 10.1089/jpm.2014.0249. Epub 2015 Feb 19. J Palliat Med. 2015. PMID: 25695199
-
[Tramadol in acute pain].Drugs. 1997;53 Suppl 2:25-33. doi: 10.2165/00003495-199700532-00007. Drugs. 1997. PMID: 9190322 Review. French.
-
[Effectiveness and tolerance of tramadol in cancer pain. A comparative study with respect to buprenorphine].Drugs. 1997;53 Suppl 2:40-9. doi: 10.2165/00003495-199700532-00009. Drugs. 1997. PMID: 9190324 Clinical Trial. French.
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
[NON-ONCOLOGIC CHRONIC PAIN TREATMENT WITH OPIATES].Rev Enferm. 2014 Sep;37(9):44-51. Rev Enferm. 2014. PMID: 26118001 Spanish.
Cited by
-
Defining Spine Cancer Pain Syndromes: A Systematic Review and Proposed Terminology.Global Spine J. 2025 Jan;15(1_suppl):81S-92S. doi: 10.1177/21925682241259686. Global Spine J. 2025. PMID: 39801118 Free PMC article.
-
Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons.Mol Pain. 2010 Dec 1;6:85. doi: 10.1186/1744-8069-6-85. Mol Pain. 2010. PMID: 21118579 Free PMC article.
-
A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain.Support Care Cancer. 2014 Mar;22(3):825-36. doi: 10.1007/s00520-013-2063-5. Epub 2013 Nov 26. Support Care Cancer. 2014. PMID: 24276956
-
Comparison of single versus multiple fractions for palliative treatment of painful bone metastasis: first study from north west India.Indian J Palliat Care. 2015 Jan-Apr;21(1):45-8. doi: 10.4103/0973-1075.150178. Indian J Palliat Care. 2015. PMID: 25709185 Free PMC article.
-
Relief of pain from osseous metastatic lesions.Drugs. 1996 Sep;52(3):475. doi: 10.2165/00003495-199652030-00014. Drugs. 1996. PMID: 8875134 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical